Chen Liu, M.D., Ph.D.

Current Titles

Professor and Chairman, Chancellor Scholar
Department of Pathology, Immunology and Laboratory Medicine

New Jersey Medical School

Professor and Chairman
Department of Pathology and Laboratory Medicine

Robert Wood Johnson Medical School

Chairman, Center for Dermatology (Department of Dermatology)

Robert Wood Johnson Medical School

Chief of Service, NJMS University Hospital in Newark and RWJ University Hospital in New Brunswick

Chief, Division of Oncological Pathology

Cancer Institute of New Jersey

Rutgers University, New Jersey, USA

Undergraduate Education
  • Tong Liao Medical College (Inner Mongolia University of Nationality) - Tong Liao, China - B.S/M.D.
Graduate Education
  • University of Pennsylvania School of Medicine - Philadelphia, PA - Ph.D.
Postgraduate Training
  • Hahnemann U. Hospital - Philadelphia, PA - Internship
  • UT MD Anderson Cancer Hospital - Houston, TX - Residency
  • Scripps Clinic - La Jolla, CA - Postdoctoral Appointment
Hospital Affiliations
  • Newark Beth Israel Hospital - Newark, NJ
  • Robert Wood Johnson University Hospital - New Brunswick, NJ
  • University Hospital - Newark, NJ
Licensure
  • State of Florida
  • State of New Jersey
Certification
  • Board Certified - Anatomic and Clinical Pathology

Honors and Awards

  • Faculty of the year, Rutgers University 2019

Board of Directors/Trustees Positions

  • Member, Board of Trustee, Rutgers Health
    2016 - Present
  • Board of Governors, Robert Wood Johnson Medical School
    2016 – Present
  • Board of University Physicians, New Jersey Medical School
    2015 – Present

Clinical Responsibilities

As the Chair of the Department of Pathology, Immunology and Laboratory Medicine, I oversee the day-to-day operations of the entire department in both Newark and New Brunswick as well as other locations.

As the Chief of Service for Gastrointestinal and Liver Pathology Service at University Hospital in Newark, I provide pathology specialty service, consultation service for patients and clinical practitioners, and administration. As a well-recognized GI/liver pathologist I also provide a large number of expert consultations for many physicians/patients.

Active Grant Support
  • Principal Investigator
NIH, NIDDK, R01DK110024-01, Liu & Robertson (MPI)
Epigenetic Mechanisms Underlying Hepatitis C-Induced Hepatocarcinogenesis
The major goal of this project is to define changes to the epigenome and transcriptome in HCV infection and HCV-associated carcinogenesis.
09/30/2017-06/30/2021

NIH, NIAAA, R01 AA027179-01, Liu & Robertson (MPI)
Epigenetic Heterogeneity as a Driver of Liver Disease and Cancer
The major goal of this project is to define how epigenomic heterogeneity plays a role in alcohol and HCV-associated liver diseases and cancer.
08/15/2018-05/31/2023

Clinical trial: Epigenomics Inc. www.clinicaltrials.gov
Trial Number: NCT03218423
Colon cancer screening using Epi ProColon test based on circulating DNA methylation
1/15/2018 – 1/14/2021
  • Co-Investigator
R01 HL125571, National Institute of Health Hanash (PI)
“Regulation of the intestinal stem cell compartment after hematopoietic transplantation”
07/01/2015-04/30/2020

R01 HL124112, National Institute of Health Jenq (PI)
“Microbiota-focused strategies to mitigate GVHD”
08/15/2015-05/31/2020

R01 AI118305, National Institute of Health, Yu (PI)
“MicroRNA Regulates Graft-versus-Host Disease”
08/01/2015-01/31/2020

P30CA72720-20 , NIH/NCI
“ Cancer Center Support Grant (CCSG)”, Libutti (PI)
03/07/2019-02/29/2024
Director, Biospecimen and Histopathology Core

UL1TR003017, National Institute of Health, Panettieri (PI)
“Clinical and Translational Science Award (CTSA)”
03/11/19-02/29/2024
Director, Pilot Development Core Program

CV and Publicatons
A list of publications along with Dr. Liu's CV can be found here.